Prognostic Factors and Indications for Treatment of Waldenström's Macroglobulinemia

Best Practice and Research in Clinical Haematology - United Kingdom
doi 10.1016/j.beha.2016.08.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

How I Treat Waldenström's Macroglobulinemia

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Prognostic Factors and Primary Treatment for Waldenström Macroglobulinemia - A Swedish Lymphoma Registry Study

British Journal of Haematology
Hematology
2018English

The Neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUS

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

The Gastrointestinal Tract, an Infrequent Target for Waldenström's Macroglobulinemia

Endoscopy
Gastroenterology
2010English

Waldenström's Macroglobulinemia in a 10-Year Stable IgG Monoclonal Gammopathy of Undetermined Significance

Leukemia Research
Cancer ResearchOncologyHematology
2009English

WhiMSICAL (WALDENSTRÖM'S MACROGLOBULINEMIA STUDY INVOLVING CArt-wheeL): A GLOBAL PATIENT-DERIVED DATA REGISTRY MAPPING TREATMENT AND QUALITY OF LIFE

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Case With Acute Renal Failure Complicated by Waldenström's Macroglobulinemia and Cryoglobulinemia

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2000English

Atacicept in Relapsed/Refractory Multiple Myeloma or Active Waldenström's Macroglobulinemia: A Phase I Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Whole-Exome Analysis of Abnormalities Leading to Waldenström's Macroglobulinemia Transformation Into Aggressive Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy